发明名称 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
摘要 A method and composition for altering a plausible sequence of pathological events in retinal ganglion cells associated with glaucoma, the sequence including membrane depolarization, influx of millimolar amounts of Na30 via non-inactivating Na30 channels, and the lethal elevation of cell Ca2+, due to reversal of the Na+/Ca2+ exchanger. The method includes blocking, by administration of a selected composition, of associated, non-inactivating Na+ channels in retinal ganglion cells in order to limit Na+/Ca+ exchange in the retinal ganglion cells and prevent buildup of the Ca2+ level in the retinal ganglion cells to a lethal level. The results in a method of preventing retinal ganglion cell death, associated with glaucoma, by acministering to the optic nerve of a mammal, a compound which blocks the non-inactivating sodium ion channels of the optic nerve. Alternately, said invention relates to a method of preventing optic retinal ganglion cell death in a human by administering to the retinal ganglion cells of said human a compound which blocks the non-inactivating sodium ion channel of the retinal ganglion cells.
申请公布号 US2002040042(A1) 申请公布日期 2002.04.04
申请号 US20010952733 申请日期 2001.09.14
申请人 ADORANTE JOSEPH S. 发明人 ADORANTE JOSEPH S.
分类号 A61K9/08;A61K9/00;A61K31/428;A61K31/496;A61K45/00;A61P27/06;A61P43/00;(IPC1-7):A61K31/428 主分类号 A61K9/08
代理机构 代理人
主权项
地址